[{"address1": "28 Wells Avenue", "address2": "3rd Floor", "city": "Yonkers", "state": "NY", "zip": "10701", "country": "United States", "phone": "914 207 2300", "website": "https://www.contrafect.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus aureus. The company also developing CF-370, an investigational anti-bacterial therapeutic candidate, which is in Phase 1 clinical trials to treat pseudomonas aeruginosa infections, such as ventilator associated pneumonia, blood stream infections, complicated urinary tract infections, and surgery carry infections. It also developing CF-296, an osteomyelitis and PJI which is in preclinical trailers for the treatment of joint infections. In addition, the company developing Exebacase for the treatment of persistent bacteremia caused by methicillin-resistant staphylococcus aureus in COVID-19 patients. Further, It develops CF-296, an engineered lysin, used for treatment of the invasive infections caused by staphylococcus aureus including biofilm-related infections in prosthetic joints and indwelling devices and osteomyelitis. The company has a license agreement with The Rockefeller University to identify novel lysin therapeutic candidates targeting gram-negative pathogens. ContraFect Corporation was incorporated in 2008 and is headquartered in Yonkers, New York. On December 4, 2023, ContraFect Corporation filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.", "fullTimeEmployees": 23, "companyOfficers": [], "auditRisk": 3, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 6, "overallRisk": 7, "governanceEpochDate": 1717200000, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.0, "open": 0.0001, "dayLow": 0.0001, "dayHigh": 0.0001, "regularMarketPreviousClose": 0.0, "regularMarketOpen": 0.0001, "regularMarketDayLow": 0.0001, "regularMarketDayHigh": 0.0001, "payoutRatio": 0.0, "beta": 0.252, "forwardPE": -6.666667e-05, "volume": 1, "regularMarketVolume": 1, "averageVolume": 1956, "averageVolume10days": 1403, "averageDailyVolume10Day": 1403, "bid": 0.0111, "ask": 0.28, "bidSize": 0, "askSize": 0, "marketCap": 1070, "fiftyTwoWeekLow": 0.0001, "fiftyTwoWeekHigh": 0.03, "fiftyDayAverage": 0.000104, "twoHundredDayAverage": 0.0030005, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": "NaN", "currency": "USD", "tradeable": false, "enterpriseValue": -2636269, "profitMargins": 0.0, "floatShares": 10703197, "sharesOutstanding": 10704800, "sharesShort": 115971, "sharesShortPriorMonth": 14111, "sharesShortPreviousMonthDate": 1694736000, "dateShortInterest": 1697155200, "sharesPercentSharesOut": 0.0108, "heldPercentInsiders": 0.00014999999, "heldPercentInstitutions": 0.13032, "shortRatio": 1.18, "shortPercentOfFloat": 0.0121, "impliedSharesOutstanding": 10705000, "bookValue": -0.538, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -24138000, "trailingEps": -15.03, "forwardEps": -1.5, "lastSplitFactor": "1:80", "lastSplitDate": 1676419200, "enterpriseToEbitda": 0.088, "52WeekChange": -0.99554765, "SandP52WeekChange": 0.09506309, "quoteType": "EQUITY", "currentPrice": 0.0001, "recommendationKey": "none", "totalCash": 5413000, "totalCashPerShare": 0.506, "ebitda": -30055000, "totalDebt": 2553000, "quickRatio": 0.439, "currentRatio": 0.529, "returnOnAssets": -1.1744, "freeCashflow": -24600750, "operatingCashflow": -35586000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CFRXQ", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "shortName": "ContraFect Corporation", "longName": "ContraFect Corporation", "marketState": "CLOSED", "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.0001, "corporateActions": [], "fiftyDayAverageChange": -4.0000014e-06, "fiftyDayAverageChangePercent": -0.03846155, "twoHundredDayAverageChange": -0.0029004999, "priceToBook": -0.0001858736, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "regularMarketChange": 0.0, "regularMarketDayRange": "1.0E-4 - 1.0E-4", "fullExchangeName": "OTC Markets EXMKT", "regularMarketTime": 1741982400, "exchange": "OEM", "messageBoardId": "finmb_112206719", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "averageDailyVolume3Month": 1956, "fiftyTwoWeekLowChange": 0.0, "fiftyTwoWeekLowChangePercent": 0.0, "fiftyTwoWeekRange": "1.0E-4 - 0.03", "fiftyTwoWeekHighChange": -0.0299, "fiftyTwoWeekHighChangePercent": -0.99666667, "fiftyTwoWeekChangePercent": -99.55476, "dividendDate": 1580774400, "earningsTimestampStart": 1742241600, "earningsTimestampEnd": 1742760000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -15.03, "epsForward": -1.5, "twoHundredDayAverageChangePercent": -0.9666722, "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1410528600000, "displayName": "ContraFect", "trailingPegRatio": null, "__fetch_time": "2025-03-15"}]